[1]
|
Wang, W.D.A.R., Wang, M., Wang, T., Qi, L., Jiang, H., et al. (2013) Expression of Brain-Specific Angiogenesis Inhibitor 1 Is Inversely Correlated with Pathological Grade, Angiogenesis and Peritumoral Brain Edema in Human Astrocytomas. Oncology Letters, 5, 1513-1518. https://doi.org/10.3892/ol.2013.1250
|
[2]
|
Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., et al. (2007) The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathologica, 114, 97-109. https://doi.org/10.1007/s00401-007-0243-4
|
[3]
|
Chandana, S.R., Movva, S., Arora, M. and Singh, T. (2008) Primary Brain Tumors in Adults. American Family Physician, 77, 1423-1430.
|
[4]
|
Etheridge, A., Lee, I., Hood, L., Galas, D. and Wang, K. (2011) Extracellular microRNA: A New Source of Biomarkers. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 717, 85-90. https://doi.org/10.1016/j.mrfmmm.2011.03.004
|
[5]
|
Xu, J., Zhao, J., Evan, G., Xiao, C., Cheng, Y. and Xiao, J. (2012) Circulating microRNAs: Novel Biomarkers for Cardiovascular Diseases. Journal of Molecular Medicine (Berlin, Germany), 90, 865-875. https://doi.org/10.1007/s00109-011-0840-5
|
[6]
|
Li, G., Morris-Blanco, K.C., Lopez, M.S., Yang, T., Zhao, H., Vemuganti, R., et al. (2018) Impact of microRNAs on Ischemic Stroke: From Pre-to Post-Disease. Progress in Neurobiology, 163-164, 59-78. https://doi.org/10.1016/j.pneurobio.2017.08.002
|
[7]
|
Tan, J.R., Koo, Y.X., Kaur, P., Liu, F., Armugam, A., Wong, P.T., et al. (2011) microRNAs in Stroke Pathogenesis. Current Molecular Medicine, 11, 76-92. https://doi.org/10.2174/156652411794859232
|
[8]
|
Lau, P., Bossers, K., Janky, R., Salta, E., Frigerio, C.S., Barbash, S., et al. (2013) Alteration of the microRNA Network during the Progression of Alzheimer’s Disease. EMBO Molecular Medicine, 5, 1613-1634. https://doi.org/10.1002/emmm.201201974
|
[9]
|
Grasso, M., Piscopo, P., Confaloni, A. and Denti, M.A. (2014) Circulating miRNAs as Biomarkers for Neurodegenerative Disorders. Molecules (Basel, Switzerland), 19, 6891-6910. https://doi.org/10.3390/molecules19056891
|
[10]
|
Stewart, L.A., Clarke, M., Rovers, M., Riley, R.D., Simmonds, M., Stewart, G., et al. (2015) Preferred Reporting Items for Systematic Review and Meta-Analyses of Individual Participant Data: The PRISMA-IPD Statement. JAMA, 313, 1657-1665. https://doi.org/10.1001/jama.2015.3656
|
[11]
|
Venkatesh, H.S., Tam, L.T., Woo, P.J., Lennon, J., Nagaraja, S., Gillespie, S.M., et al. (2017) Targeting Neuronal Activity-Regulated Neuroligin-3 Dependency in High-Grade Glioma. Nature, 549, 533-537. https://doi.org/10.1038/nature24014
|
[12]
|
Zhang, B.L., Guo, T.W., Gao, L.L., Ji, G.Q., Gu, X.H., Shao, Y.Q., et al. (2017) Egr-1 and RNA POL II Facilitate Glioma Cell GDNF Transcription Induced by Histone Hyperacetylation in Promoter II. Oncotarget, 8, 45105-45116. https://doi.org/10.18632/oncotarget.15126
|
[13]
|
Lv, D., Jia, F., Hou, Y., Sang, Y., Alvarez, A.A., Zhang, W., et al. (2017) Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding. Cancer Research, 77, 6190-6201. https://doi.org/10.1158/0008-5472.CAN-17-1388
|
[14]
|
Bai, J., Xiao, L., Tao, Z., Cao, B., Han, Y., Fan, W., et al. (2018) Ectopic Expression of E3 Ubiquitin-Protein Ligase 2 in Glioma and Enhances Resistance to Apoptosis through Activating Nuclear Factor κ-Light-Chain-Enhancer of B Cells. Oncology Letters, 16, 4391-4399. https://doi.org/10.3892/ol.2018.9153
|
[15]
|
Pan, S.J., Zhan, S.K., Ji, W.Z., Pan, Y.X., Liu, W., Li, D.Y., et al. (2015) Ubiquitin-Protein Ligase E3C Promotes Glioma Progression by Mediating the Ubiquitination and Degrading of Annexin A7. Scientific Reports, 5, Article No. 11066. https://doi.org/10.1038/srep11066
|
[16]
|
Shi, Q., Song, X., Wang, J., Gu, J., Zhang, W., Hu, J., et al. (2015) FRK Inhibits Migration and Invasion of Human Glioma Cells by Promoting N-Cadherin/β-Catenin Complex Formation. Journal of Molecular Neuroscience: MN, 55, 32-41. https://doi.org/10.1007/s12031-014-0355-y
|
[17]
|
Yu, O.M., Benitez, J.A., Plouffe, S.W., Ryback, D., Klein, A., Smith, J., et al. (2018) YAP and MRTF-A, Transcriptional Co-Activators of RhoA-Mediated Gene Expression, Are Critical for Glioblastoma Tumorigenicity. Oncogene, 37, 5492-5507. https://doi.org/10.1038/s41388-018-0301-5
|
[18]
|
González-Orozco, J.C., Hansberg-Pastor, V., Valadez-Cosmes, P., Nicolas-Ortega, W., Bastida-Beristain, Y., Fuente-Granada, M., et al. (2018) Activation of Membrane Progesterone Receptor-Alpha Increases Proliferation, Migration, and Invasion of Human Glioblastoma Cells. Molecular and Cellular Endocrinology, 477, 81-89. https://doi.org/10.1016/j.mce.2018.06.004
|
[19]
|
Bao, D., Cheng, C., Lan, X., Xing, R., Chen, Z., Zhao, H., et al. (2017) Regulation of P53wt Glioma Cell Proliferation by Androgen Receptor-Mediated Inhibition of Small VCP/P97-Interacting Protein Expression. Oncotarget, 8, 23142-23154. https://doi.org/10.18632/oncotarget.15509
|
[20]
|
Davis, F.B., Tang, H.Y., Shih, A., Keating, T., Lansing, L., Hercbergs, A., et al. (2006) Acting via a Cell Surface Receptor, Thyroid Hormone Is a Growth Factor for Glioma Cells. Cancer Research, 66, 7270-7275. https://doi.org/10.1158/0008-5472.CAN-05-4365
|
[21]
|
Yang, J., Gan, X., Tan, B., Wang, J. and Chen, Y. (2019) Corticotropin-Releasing Factor Suppresses Glioma Progression by Upregulation of Long Non-Coding RNA-P21. Life Sciences, 216, 92-100. https://doi.org/10.1016/j.lfs.2018.07.003
|
[22]
|
Wade, A., Robinson, A.E., Engler, J.R., Petritsch, C., James, C.D. and Phillips, J.J. (2013) Proteoglycans and Their Roles in Brain Cancer. The FEBS Journal, 280, 2399-2417. https://doi.org/10.1111/febs.12109
|
[23]
|
Theocharis, A.D., Skandalis, S.S., Tzanakakis, G.N. and Karamanos, N.K. (2010) Proteoglycans in Health and Disease: Novel Roles for Proteoglycans in Malignancy and Their Pharmacological Targeting. The FEBS Journal, 277, 3904-3923. https://doi.org/10.1111/j.1742-4658.2010.07800.x
|
[24]
|
Wang, B.Q., Yang, B., Yang, H.C., Wang, J.Y., Hu, S., Gao, Y.S., et al. (2018) microRNA-499a Decelerates Glioma Cell Proliferation While Accelerating Apoptosis through the Suppression of Notch1 and the MAPK Signaling Pathway. Brain Research Bulletin, 142, 96-106. https://doi.org/10.1016/j.brainresbull.2018.06.005
|
[25]
|
Liu, Z., Wei, Y., Zhang, L., Yee, P.P., Johnson, M., Zhang, X., et al. (2019) Induction of Store-Operated Calcium Entry (SOCE) Suppresses Glioblastoma Growth by Inhibiting the Hippo Pathway Transcriptional Coactivators YAP/TAZ. Oncogene, 38, 120-139. https://doi.org/10.1038/s41388-018-0425-7
|
[26]
|
Nan, Y., Guo, H., Guo, L., Wang, L., Ren, B., Yu, K., et al. (2018) miRNA-451 Inhibits Glioma Cell Proliferation and Invasion through the MTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39. Human Gene Therapy. Clinical Development, 29, 156-166. https://doi.org/10.1089/humc.2018.133
|
[27]
|
Liao, Y.X., Zhang, Z.P., Zhao, J. and Liu, J.P. (2018) Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells through the PI3K/AKT Signaling Pathway. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 48, 1382-1396. https://doi.org/10.1159/000492096
|
[28]
|
Zhang, T., Jiang, K., Zhu, X., Zhao, G., Wu, H., Deng, G., et al. (2018) MiR-433 Inhibits Breast Cancer Cell Growth via the MAPK Signaling Pathway by Targeting Rap1a. International Journal of Biological Sciences, 14, 622-632. https://doi.org/10.7150/ijbs.24223
|
[29]
|
Zhang, X., Yang, R., Hu, B.L., Lu, P., Zhou, L.L., He, Z.Y., et al. (2017) Reduced Circulating Levels of MiR-433 and MiR-133b Are Potential Biomarkers for Parkinson’s Disease. Frontiers in Cellular Neuroscience, 11, Article No. 170. https://doi.org/10.3389/fncel.2017.00170
|
[30]
|
Sun, S., Wang, X., Xu, X., Di, H., Du, J., Xu, B., et al. (2017) MiR-433-3p Suppresses Cell Growth and Enhances Chemosensitivity by Targeting CREB in Human Glioma. Oncotarget, 8, 5057-5068. https://doi.org/10.18632/oncotarget.13789
|
[31]
|
Noyan, S., Gurdal, H. and Gur Dedeoglu, B. (2019) Involvement of MiR-770-5p in Trastuzumab Response in HER2 Positive Breast Cancer Cells. PLOS ONE, 14, E0215894. https://doi.org/10.1371/journal.pone.0215894
|
[32]
|
Zhang, S.Z., Qiu, X.J., Dong, S.S., Zhou, L.N., Zhu, Y., Wang, M.D., et al. (2019) microRNA-770-5p Is Involved in the Development of Diabetic Nephropathy through Regulating Podocyte Apoptosis by Targeting TP53 Regulated Inhibitor of Apoptosis 1. European Review for Medical and Pharmacological Sciences, 23, 1248-1256.
|
[33]
|
Lin, J.F., Zeng, H. and Zhao, J.Q. (2018) MiR-212-5p Regulates the Proliferation and Apoptosis of AML Cells through Targeting FZD5. European Review for Medical and Pharmacological Sciences, 22, 8415-8422.
|
[34]
|
Xiao, X., Jiang, Y., Liang, W., Wang, Y., Cao, S., Yan, H., et al. (2019) MiR-212-5p Attenuates Ferroptotic Neuronal Death after Traumatic Brain Injury by Targeting Ptgs2. Molecular Brain, 12, 78. https://doi.org/10.1186/s13041-019-0501-0
|
[35]
|
Deng, J.H., Zheng, G.Y., Li, H.Z. and Ji, Z.G. (2019) MiR-212-5p Inhibits the Malignant Behavior of Clear Cell Renal Cell Carcinoma Cells by Targeting TBX15. European Review for Medical and Pharmacological Sciences, 23, 10699-10707.
|
[36]
|
Zhang, C., Gou, X., He, W.Y., Yang, H.A. and Yin, H.B. (2020) A Glycolysis-Based 4-MRNA Signature Correlates with the Prognosis and Cell Cycle Process in Patients with Bladder Cancer. Cancer Cell International, 20, Article No. 177. https://doi.org/10.1186/s12935-020-01255-2
|
[37]
|
Liu, X., Kang, J., Sun, S., Luo, Y., Ji, X., Zeng, X., et al. (2018) IASPP, a microRNA-124 Target, Is Aberrantly Expressed in Astrocytoma and Regulates Malignant Glioma Cell Migration and Viability. Molecular Medicine Reports, 17, 1970-1978. https://doi.org/10.3892/mmr.2017.8097
|
[38]
|
Xu, J., Liu, Y., Guo, S., Ma, S., Xiao, L., Wei, N., et al. (2016) Expression Profile of MiR-128 in the Astrocytoma Patients and Cell Lines. Molecular Neurobiology, 53, 4631-4637. https://doi.org/10.1007/s12035-015-9401-1
|
[39]
|
Bookland, M., Tang-Schomer, M., Gillan, E. and Kolmakova, A. (2018) Circulating Serum Oncologic miRNA in Pediatric Juvenile Pilocytic Astrocytoma Patients Predicts Mural Nodule Volume. Acta Neurochirurgica, 160, 1571-1581. https://doi.org/10.1007/s00701-018-3589-6
|
[40]
|
Deshpande, R.P., Chandra Sekhar, Y.B.V.K., Panigrahi, M. and Babu, P.P. (2017) SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-MiR-520d-5p and Hsa-MiR-520d-3p. Molecular Neurobiology, 54, 8162-8169. https://doi.org/10.1007/s12035-016-0302-8
|
[41]
|
Zhi, F., Chen, X., Wang, S., Xia, X., Shi, Y., Guan, W., et al. (2010) The Use of Hsa-MiR-21, Hsa-MiR-181b and Hsa-MiR-106a as Prognostic Indicators of Astrocytoma. European Journal of Cancer (Oxford, England: 1990), 46, 1640-1649. https://doi.org/10.1016/j.ejca.2010.02.003
|
[42]
|
Zhi, F., Wang, Q., Deng, D., Shao, N., Wang, R., Xue, L., et al. (2014) MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma. PLOS ONE, 9, e109124. https://doi.org/10.1371/journal.pone.0109124
|
[43]
|
Deng, D., Wang, L., Chen, Y., Li, B., Xue, L., Shao, N., et al. (2016) microRNA-124-3p Regulates Cell Proliferation, Invasion, Apoptosis, and Bioenergetics by Targeting PIM1 in Astrocytoma. Cancer Science, 107, 899-907. https://doi.org/10.1111/cas.12946
|
[44]
|
Zhi, F., Shao, N., Wang, R., Deng, D., Xue, L., Wang, Q., et al. (2015) Identification of 9 Serum microRNAs as Potential Noninvasive Biomarkers of Human Astrocytoma. Neuro-Oncology, 17, 383-391. https://doi.org/10.1093/neuonc/nou169
|
[45]
|
Huang, L., Li, X., Ye, H., Liu, Y., Liang, X., Yang, C., et al. (2020) Long Non-Coding RNA NCK1-AS1 Promotes the Tumorigenesis of Glioma through Sponging microRNA-138-2-3p and Activating the TRIM24/Wnt/β-Catenin Axis. Journal of Experimental & Clinical Cancer Research: CR, 39, 63. https://doi.org/10.1186/s13046-020-01567-1
|
[46]
|
Wu, H., Liu, H.Y., Liu, W.J., Shi, Y.L. and Bao, D. (2018) MiR-377-5p Inhibits Lung Cancer Cell Proliferation, Invasion, and Cell Cycle Progression by Targeting AKT1 Signaling. Journal of Cellular Biochemistry, 120, 8120-8128. https://doi.org/10.1002/jcb.28091
|
[47]
|
Li, C., Dong, Q., Che, X., Xu, L., Li, Z., Fan, Y., et al. (2018) microRNA-29b-2-5p Inhibits Cell Proliferation by Directly Targeting Cbl-B in Pancreatic Ductal Adenocarcinoma. BMC Cancer, 18, Article No. 681. https://doi.org/10.1186/s12885-018-4526-z
|
[48]
|
Jin, J., Zhou, S., Li, C., Xu, R., Zu, L., You, J., et al. (2014) MiR-517a-3p Accelerates Lung Cancer Cell Proliferation and Invasion through Inhibiting FOXJ3 Expression. Life Sciences, 108, 48-53. https://doi.org/10.1016/j.lfs.2014.05.006.
|